APA (7th ed.) Citation

Young, J., Weis, N., Hofer, H., Irving, W., Weiland, O., Giostra, E., . . . Calleja, J. L. (2017). The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease. BMC Infectious Diseases, 17, 1. https://doi.org/10.1186/s12879-016-2106-x

Chicago Style (17th ed.) Citation

Young, Jim, et al. "The Effectiveness of Daclatasvir Based Therapy in European Patients with Chronic Hepatitis C and Advanced Liver Disease." BMC Infectious Diseases 17 (2017): 1. https://doi.org/10.1186/s12879-016-2106-x.

MLA (9th ed.) Citation

Young, Jim, et al. "The Effectiveness of Daclatasvir Based Therapy in European Patients with Chronic Hepatitis C and Advanced Liver Disease." BMC Infectious Diseases, vol. 17, 2017, p. 1, https://doi.org/10.1186/s12879-016-2106-x.